Karyopharm to Report First Quarter 2024 Financial Results on May 8, 2024
— Conference Call Scheduled for Wednesday, May 8, 2024, at 8:00 a.m. ET —
NEWTON, Mass., May 2, 2024 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report first quarter 2024 financial results on Wednesday, May 8, 2024. Karyopharm’s management team will host a conference call and audio webcast at 8:00 a.m. ET on Wednesday, May 8, 2024, to discuss the financial results and other company updates.